在Anopheles gambiae中自然疟疾感染是由单个基因组控制区域调节的
Michelle M Riehle1, Kyriacos Markianos, Oumou Niaré
1Center for Microbial and Plant Genomics and Department of Microbiology, University of Minnesota, St. Paul, MN 55108, USA.
Science (New York, N.Y.)
|April 29, 2006
概括
科学家们在Anopheles gambiae蚊子中确定了关键的基因位置,这些基因位置赋予了对疟疾寄生虫Plasmodium falciparum的抵抗力. 这些抗杆菌的Anopheles Plasmodium位点,特别是APL1,对于控制西非疟疾传播至关重要.
科学领域:
- 遗传学 是一个遗传学.
- 昆虫学 昆虫学是一门学科.
- 寄生虫学的寄生虫学
背景情况:
- 疟疾仍然是一个重大的全球卫生挑战,由阿诺菲莱斯蚊子传播.
- 了解影响Plasmodium falciparum感染的蚊子遗传因素对于疟疾控制策略至关重要.
研究的目的:
- 为了确定Anopheles gambiae中的遗传基因位点,这些基因位点赋予了对Plasmodium falciparum感染的自然抵抗力.
- 研究特定基因,如APL1在蚊子疟疾耐药性中的作用.
主要方法:
- 在西非疟疾传播区调查Anopheles gambiae种群.
- 利用遗传分析来识别耐药性的位置.
- 进行RNA干扰 (RNAi) 敲击测试以验证基因功能.
主要成果:
- 鉴定了2L染色体上强烈的Plasmodium耐药位点集群,解释了89%以上的无寄生虫蚊子.
- 这些位点形成了一个"基因组等离子体耐药性岛屿",占蚊子感染中大多数自然遗传变异的比例.
- 通过RNAi证实了Anopheles Plasmodium响应性氨酸丰富的重复1 (APL1) 在Plasmodium耐药性中的作用.
结论:
- 2L染色体上的一个小的基因组区域含有控制Anopheles gambiae易受Plasmodium falciparum的关键遗传因素.
- APL1基因是蚊子对疟疾寄生虫自然防御的关键组成部分.
- 这些发现提供了通过操纵蚊子遗传学的新型疟疾控制干预措施的潜在目标.
相关概念视频
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...